Research | Clinical Trials | Clinical Trial Details Page

Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse

Conditions

Cocaine Dependence

What is the purpose of this trial?

We are testing to see if Galantamine, a learning enhancing medication, will help methadone maintained cocaine abusers with their learning and memory specific to CBT using an innovative CBT computer program.


Participation Guidelines

Age:
18 Years - 50 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.

Sponsor:
National Institute on Drug Abuse (NIDA)
Yale University
Dates:
December 2007
Last Updated:
September 26, 2011
Study HIC#:
0708002943

Clinicaltrials.gov ID: NCT00809835